🇺🇸 STRIBILD in United States

26,019 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bone Density Decreased — 4,550 reports (17.49%)
  2. Renal Injury — 3,304 reports (12.7%)
  3. Skeletal Injury — 3,020 reports (11.61%)
  4. Chronic Kidney Disease — 2,482 reports (9.54%)
  5. Tooth Loss — 2,455 reports (9.44%)
  6. Bone Loss — 2,134 reports (8.2%)
  7. Osteonecrosis — 2,095 reports (8.05%)
  8. Renal Failure — 2,052 reports (7.89%)
  9. Tooth Injury — 1,970 reports (7.57%)
  10. Multiple Fractures — 1,957 reports (7.52%)

Source database →

STRIBILD in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is STRIBILD approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for STRIBILD in United States?

Vancouver Infectious Diseases Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.